简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-12-17 19:07 Personalis Launches NeXT Personal™, A Tumor-Informed Liquid Biopsy Assay for MRD and Recurrence Detection With Part-Per-Million Sensitivity
2021-12-17 11:29 Boyd Corporation Acquires MBK Tape Solutions, Expands Biosensor, Transdermal Patch, and Medical Wearable Expertise
2021-12-17 09:31 Navient Neuro-navigation System Receives Chinese Regulatory Clearance
2021-12-16 16:25 Microba Life Sciences Becomes First Australian Microbiome Company Granted ISO15189 Accreditation by NATA
2021-12-16 14:40 Vifor Pharma drives transformation with divestment of non-core finished drug manufacturing to CordenPharma
2021-12-15 16:32 PCI Pharma Services Announces the Closing of Its Acquisition of LSNE
2021-12-15 14:26 Retrace AV Launches New Paint Product That Destroys SARS-CoV-2, the COVID-19 Virus Within 30 Minutes
2021-12-15 10:24 Organon Completes Acquisition of Forendo Pharma
2021-12-15 09:29 BostonGene and NEC Announce Global Partnership
2021-12-14 16:25 New Study Suggests That Masimo SedLine® Brain Function Monitoring May Aid Early Identification of Patients at Risk of Developing Postoperative Delirium
2021-12-14 15:31 CSL Limited announces tender offer to acquire Vifor Pharma Ltd
2021-12-13 19:29 Researchers to Investigate the Gut-Brain Axis in Soldiers With Microba’s Technology
2021-12-13 19:23 The Kavli Foundation Launches Two Kavli Centers for Ethics, Science, and the Public to Engage the Public in Exploring Ethical Implications Born from Scientific Discovery
2021-12-13 16:35 Aerogen® and CanSinoBIO agree on landmark development and commercial supply partnership for world’s first inhaled Covid-19 vaccine delivery
2021-12-13 16:32 Vifor Pharma comments on media speculation
2021-12-13 10:00 KOREA PACK & ICPI WEEK (Int’l Cosmetic and Pharmaceutical Industry Week) 2022 to Provide O2O Service Connecting Offline Exhibition to the Online Business Platform
2021-12-13 09:31 First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
2021-12-10 14:33 Vifor Pharma appoints Hervé Gisserot as new Chief Commercial Officer and member of the Executive Committee
2021-12-10 14:31 Vifor Pharma and Angion report topline results from phase-II GUARD trial of ANG-3777 in cardiac surgery associated acute kidney injury
2021-12-10 12:24 LintonPharm Announces First Patient Dosed in Phase 1 Clinical Trial of Catumaxomab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin

Business Wire Weibo

Press Releases

Latest Releases